[Novelties and experience with tyrosine kinase inhibitor therapy in chronic myeloid leukemia]
{{output}}
The introduction of tyrosine kinase inhibitor (TKI) treatment has resulted in dramatically improved survival in chronic myeloid leukemia (CML). With the new generation of TKIs the majority of patients reach optimal molecular response. Due to the improving surv... ...
